Should psychiatrists be more cautious about the use of antipsychotics for patients with borderline personality disorder?

Braz J Psychiatry. 2022 Nov 5;44(5):467-468. doi: 10.47626/1516-4446-2022-2574. Epub 2022 Jun 21.

Authors

Rodolfo Furlan Damiano¹, Jair C Soares²

Affiliations

¹ Departamento e Instituto de Psiquiatria, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (HCFMUSP), São Paulo, SP, Brazil.
² Center of Excellence on Mood Disorders, Faillace Department of Psychiatry and Behavioral Sciences, McGovern Medical School and Executive Director, Harris County Psychiatric Center, The University of Texas Health Science Center (UTHealth), Houston, TX, United States.

No abstract available

Publication types

Editorial

MeSH terms

Antipsychotic Agents* / adverse effects
Borderline Personality Disorder* / drug therapy
Humans
Psychiatry*

Substances

Antipsychotic Agents